Related Experiment Video
Updated: May 15, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Proposed interaction between angiotensinogen and retinoblastoma tumor suppressor protein: Potential molecular origin
Insights
This study proposes a new hypothesis: intracellular angiotensinogen inactivates the retinoblastoma tumor suppressor protein (RB), driving hypertension. Targeting angiotensinogen could be a novel antihypertensive strategy.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Oncology
Background:
- Hypertension is a major global health challenge.
- The renin-angiotensin system is crucial in blood pressure regulation.
- The retinoblastoma tumor suppressor protein (RB) is a key regulator of cell proliferation.
Discussion:
- This work introduces a novel hypothesis implicating intracellular angiotensinogen in hypertension pathogenesis.
- The hypothesis suggests angiotensinogen inactivates the retinoblastoma tumor suppressor protein (RB).
- This inactivation leads to an inflammatory and hyperproliferative state, contributing to elevated blood pressure.
Key Insights:
- Intracellular angiotensinogen's novel role in hypertension.
- Mechanism linking angiotensinogen, RB inactivation, and hypertensive pathophysiology.
- Potential therapeutic target: neutralizing angiotensinogen.
Outlook:
- Further research to validate the proposed mechanism.
- Development of RB-derived compounds or angiotensinogen inhibitors as antihypertensive therapies.
- Exploring the role of intracellular angiotensinogen in other cardiovascular diseases.
Abstract:
Hypertension ranks among the most important disease challenges on a global scale. Here, a novel hypothesis is presented which implicates angiotensinogen, i.e. the precursor protein for the hypertensive peptide angiotensin II, as a key culprit in the pathogenesis of hypertension. This hypothesis more precisely entails that intracellular angiotensinogen binds and thereby inactivates the retinoblastoma tumor suppressor protein (RB), consequently leading to an inflammatory and hyperproliferative state that significantly contributes to pathologically increasing blood pressure. Accordingly, a conceivable antihypertensive strategy could comprise RB-derived compounds that neutralize angiotensinogen.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Hypertension II: Pathophysiology
Regulation of Angiogenesis and Blood Supply
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers

